跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-ALENDRONATE 10MG TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
APO-ALENDRONATE 10MG TABLET
Approved
THERAPEUTIC
APO-ALENDRONATE 10MG TABLET
APOTEX INC (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Oct 7, 2008
Approval ID
f7e6e3d2b3aa854c
Company
APOTEX INC (CANADA)
Type
Therapeutic
Approval Details
Approval Id
f7e6e3d2b3aa854c
Drug Name
APO-ALENDRONATE 10MG TABLET
Product Name
APO-ALENDRONATE 10MG TABLET
Approval Number
SIN13558P
Approval Date
2008-10-07
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
M05BA04
Atc Item Name
alendronic acid
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
Alendronate (eqv Alendronate Sodium Trihydrate 13.05mg)
10.0 mg
Alendronate (eqv Alendronate Sodium Trihydrate 13.05mg)
10.0 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 7, 2008
Approval ID
f7e6e3d2b3aa854c
Type
Therapeutic
Back to HSA Approvals